The researchers therefore used data from three large U.S
Koberlein GC, Trout AT, Rigsby CK, et al
To read more in detail (and explore the research further): Not to mention preliminary studies suggesting that GLP-1 agonists may reduce alcohol consumption by modulating brain reward pathways, as seen in animal models
It covers 0.5mg (10 units), 1mg (20 units), 2mg (40 units), and 4mg (80 units), all within a single 1mL syringe
Additionally, in a Phase II clinical trial targeting a population with Metabolism-Associated Steatohepatitis (MASLD), treatment with 2.4 mg of pemvidutide for 24 weeks resulted in a relative liver fat content reduction of up to 76% as opposed to the placebo group's 14%